Bilirubin binding to hepatic Y and Z protein (ligandin): tissue bilirubin concentrations in phenobarbital treated Gunn rats (38466).
NaP treatment significantly reduced plasma bilirubin levels in the (jj) Gunn rat. It is suggested that NaP significantly increased extravascular bilirubin binding in the liver by induction of the synthesis of Y anion binding protein. The changes in bilirubin concentration of blood and other tissues subsequent to NaP treatment were consistent with the establishment of a new tissue bilirubin equilibrium.
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D001663:Bilirubin / Q000097:blood / Q000378:metabolism*; D001921:Brain / Q000378:metabolism; D003593:Cytoplasm / Q000378:metabolism*; D006932:Hyperbilirubinemia / Q000188:drug therapy*; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism* / Q000648:ultrastructure; D008168:Lung / Q000378:metabolism; D008297:Male; D009206:Myocardium / Q000378:metabolism; D010179:Pancreas / Q000378:metabolism; D010634:Phenobarbital / Q000627:therapeutic use*; D011485:Protein Binding; D051381:Rats; D012867:Skin / Q000378:metabolism; D013154:Spleen / Q000378:metabolism; D013737:Testis / Q000378:metabolism; D013997:Time Factors
D001663:Bilirubin; D010634:Phenobarbital